- Amneal Pharmaceuticals ( NYSE: AMRX ) is scheduled to announce Q2 earnings results on Thursday, August 4th, before market open.
- The consensus EPS Estimate is $0.19 (-24.0% Y/Y) and the consensus Revenue Estimate is $534.44M (-0.1% Y/Y).
- Over the last 2 years, AMRX has beaten EPS estimates 75% of the time and has beaten revenue estimates 63% of the time.
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 5 downward. Revenue estimates have seen 0 upward revisions and 6 downward.
For further details see:
Amneal Pharmaceuticals Q2 2022 Earnings Preview